BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 10713059)

  • 1. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.
    Miura S; Li CQ; Cao Z; Wang H; Wardell MR; Sadler JE
    J Biol Chem; 2000 Mar; 275(11):7539-46. PubMed ID: 10713059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of GPIbalpha-vWF-A1 tether bond under flow: effect of GPIbalpha mutations on the association and dissociation rates.
    Kumar RA; Dong JF; Thaggard JA; Cruz MA; López JA; McIntire LV
    Biophys J; 2003 Dec; 85(6):4099-109. PubMed ID: 14645097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
    Martin C; Morales LD; Cruz MA
    J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
    Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha.
    Bonnefoy A; Yamamoto H; Thys C; Kito M; Vermylen J; Hoylaerts MF
    Blood; 2003 Feb; 101(4):1375-83. PubMed ID: 12393553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.
    Ju L; Dong JF; Cruz MA; Zhu C
    J Biol Chem; 2013 Nov; 288(45):32289-32301. PubMed ID: 24062306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha.
    Cauwenberghs N; Vanhoorelbeke K; Vauterin S; Westra DF; Romo G; Huizinga EG; Lopez JA; Berndt MC; Harsfalvi J; Deckmyn H
    Blood; 2001 Aug; 98(3):652-60. PubMed ID: 11468163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
    Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
    J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.
    Nishio K; Anderson PJ; Zheng XL; Sadler JE
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10578-83. PubMed ID: 15249683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations.
    Dumas JJ; Kumar R; McDonagh T; Sullivan F; Stahl ML; Somers WS; Mosyak L
    J Biol Chem; 2004 May; 279(22):23327-34. PubMed ID: 15039442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet GpIba binding to von Willebrand Factor under fluid shear:contributions of the D′D3-domain, A1-domain flanking peptide and O-linked glycans.
    Madabhushi SR; Zhang C; Kelkar A; Dayananda KM; Neelamegham S
    J Am Heart Assoc; 2014 Oct; 3(5):e001420. PubMed ID: 25341886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
    Ward CM; Andrews RK; Smith AI; Berndt MC
    Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific electrostatic interactions between charged amino acid residues regulate binding of von Willebrand factor to blood platelets.
    Interlandi G; Yakovenko O; Tu AY; Harris J; Le J; Chen J; López JA; Thomas WE
    J Biol Chem; 2017 Nov; 292(45):18608-18617. PubMed ID: 28924049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
    Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
    J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine-rich repeats 2-4 (Leu60-Glu128) of platelet glycoprotein Ibalpha regulate shear-dependent cell adhesion to von Willebrand factor.
    Shen Y; Cranmer SL; Aprico A; Whisstock JC; Jackson SP; Berndt MC; Andrews RK
    J Biol Chem; 2006 Sep; 281(36):26419-23. PubMed ID: 16774914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V.
    Ulrichts H; Udvardy M; Lenting PJ; Pareyn I; Vandeputte N; Vanhoorelbeke K; Deckmyn H
    J Biol Chem; 2006 Feb; 281(8):4699-707. PubMed ID: 16373331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.
    Matsushita T; Sadler JE
    J Biol Chem; 1995 Jun; 270(22):13406-14. PubMed ID: 7539426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.